Variant report
Variant | esv2762320 |
---|---|
Chromosome Location | chr3:22358353-22364399 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs570954435 | chr3:22360008-22360009 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs552265546 | chr3:22360023-22360024 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs570567624 | chr3:22360033-22360034 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs370200103 | chr3:22360037-22360038 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs528577308 | chr3:22360051-22360052 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs190171884 | chr3:22360088-22360089 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs17011204 | chr3:22360104-22360105 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs536175450 | chr3:22360114-22360115 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs558333268 | chr3:22360134-22360135 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs144649012 | chr3:22360170-22360171 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs181681210 | chr3:22360175-22360176 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs111699219 | chr3:22360183-22360184 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs563976605 | chr3:22360184-22360185 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs565833975 | chr3:22360201-22360202 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs557783604 | chr3:22360235-22360236 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs572931240 | chr3:22360258-22360259 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs76177242 | chr3:22360274-22360275 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs376443279 | chr3:22360280-22360281 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs573724380 | chr3:22360324-22360325 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs565852351 | chr3:22360351-22360352 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs186171948 | chr3:22360363-22360364 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs534921558 | chr3:22360369-22360370 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs544117396 | chr3:22360407-22360408 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs562404944 | chr3:22360445-22360446 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs190494813 | chr3:22360458-22360459 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs372111282 | chr3:22360503-22360504 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs564314531 | chr3:22360520-22360521 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs113131942 | chr3:22360563-22360564 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs546757258 | chr3:22360576-22360577 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs568661652 | chr3:22360585-22360586 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs12497224 | chr3:22360628-22360629 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs551298027 | chr3:22360663-22360664 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs569616433 | chr3:22360746-22360747 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs540127887 | chr3:22360747-22360748 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs557818241 | chr3:22360752-22360753 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs566320624 | chr3:22360758-22360759 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs143792009 | chr3:22360773-22360774 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs536191024 | chr3:22360862-22360863 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs555133494 | chr3:22360905-22360906 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs573790642 | chr3:22360915-22360916 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs543958382 | chr3:22360922-22360923 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs11129050 | chr3:22360972-22360973 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs537069506 | chr3:22360977-22360978 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs184068297 | chr3:22360998-22360999 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs564533707 | chr3:22361022-22361023 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs573128684 | chr3:22361037-22361038 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs147245905 | chr3:22361043-22361044 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs561993437 | chr3:22361046-22361047 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs189178962 | chr3:22361053-22361054 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs533767732 | chr3:22361062-22361063 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 17603634 | CNVD |
Neuroblastoma | 17327916 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Melanoma | 18172304 | CNVD |
Cervical cancer | 21062161 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Insulin resistance | 16721378 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Oral cancer | 19627613 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Epithelial cancer | 22065749 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Liposarcoma | 21253554 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Pancreatic endocrine tumor | 20981439 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oral cancer | 21386901 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Retinoblastoma | 21504564 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Intellectual disability | 22102821 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Gastric adenocarcinoma | 19115996 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Esophageal squamous carcinoma | 17470683 | CNVD |
Breast cancer | 17133270 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Autism | 22495311 | CNVD |
Cancer | 20164919 | CNVD |
Melanoma | 20688739 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:22360000-22361200 | Enhancers | Fetal Lung | lung |
2 | chr3:22360200-22360600 | Enhancers | Liver | Liver |
3 | chr3:22360400-22361600 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
4 | chr3:22360800-22361200 | Enhancers | Liver | Liver |
5 | chr3:22361200-22361600 | Enhancers | Pancreatic Islets | Pancreatic Islet |
6 | chr3:22361200-22368000 | Weak transcription | Fetal Lung | lung |
7 | chr3:22364200-22365000 | Enhancers | HUES6 Cell Line | embryonic stem cell |
8 | chr3:22364200-22365000 | Enhancers | HUES64 Cell Line | embryonic stem cell |
9 | chr3:22364200-22365000 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
10 | chr3:22364200-22365000 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
11 | chr3:22364200-22365000 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
12 | chr3:22364200-22365400 | Enhancers | HUES48 Cell Line | embryonic stem cell |